[1] |
SUNG H, FERLAY J, SIEGEL R L, et al. Global Cancer Statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3):209-249. doi:10.3322/caac.21660.
|
[2] |
TORRE L A, TRABERT B, DESANTIS C E, et al. Ovarian cancer statistics,2018[J]. CA Cancer J Clin, 2018, 68(4):284-296. doi:10.3322/caac.21456.
|
[3] |
MOMENIMOVAHED Z, TIZNOBAIK A, TAHERI S, et al. Ovarian cancer in the world: epidemiology and risk factors[J]. Int J Womens Health, 2019, 11:287-299. doi:10.2147/IJWH.S197604.
|
[4] |
FLYNN M J, LEDERMANN J A. Ovarian cancer recurrence:Is the definition of platinum resistance modified by PARPi and other intervening treatments? The evolving landscape in the management of platinum-resistant ovarian cancer[J]. Cancer Drug Resist, 2022, 5(2):424-435. doi:10.20517/cdr.2022.13.
|
[5] |
HARA T, KASHIHARA D, ICHIMURA A, et al. Role of free fatty acid receptors in the regulation of energy metabolism[J]. Biochim Biophys Acta, 2014, 1841(9):1292-1300. doi:10.1016/j.bbalip.2014.06.002.
|
[6] |
DRANSE H J, KELLY M E, HUDSON B D. Drugs or diet?--Developing novel therapeutic strategies targeting the free fatty acid family of GPCRs[J]. Br J Pharmacol, 2013, 170(4):696-711. doi:10.1111/bph.12327.
|
[7] |
ICHIMURA A, HASEGAWA S, KASUBUCHI M, et al. Free fatty acid receptors as therapeutic targets for the treatment of diabetes[J]. Front Pharmacol, 2014, 5:236. doi:10.3389/fphar.2014.00236.
|
[10] |
TALUKDAR S, OLEFSKY J M, OSBORN O. Targeting GPR120 and other fatty acid-sensing GPCRs ameliorates insulin resistance and inflammatory diseases[J]. Trends Pharmacol Sci, 2011, 32(9):543-550. doi:10.1016/j.tips.2011.04.004.
|
[8] |
ZHANG M, QIU S. Activation of GPR120 promotes the metastasis of breast cancer through the PI3K/Akt/NF-κB signaling pathway[J]. Anticancer Drugs, 2019, 30(3):260-270. doi:10.1097/CAD.0000000000000716.
|
[9] |
TAKAHASHI K, FUKUSHIMA K, ONISHI Y, et al. Involvement of FFA1 and FFA4 in the regulation of cellular functions during tumor progression in colon cancer cells[J]. Exp Cell Res, 2018, 369(1):54-60. doi:10.1016/j.yexcr.2018.05.005.
|
[10] |
ZHANG L, ZHAO X, CHU H, et al. Serum free fatty acids and G-coupled protein receptors are associated with the prognosis of epithelial ovarian cancer[J]. Front Oncol, 2022, 12:777367. doi:10.3389/fonc.2022.777367.
|
[11] |
HOPKINS M M, MEIER K E. Free fatty acid receptor (FFAR) agonists inhibit proliferation of human ovarian cancer cells[J]. Prostaglandins Leukot Essent Fatty Acids, 2017, 122:24-29. doi:10.1016/j.plefa.2017.06.013.
|
[12] |
MUNKARAH A, MERT I, CHHINA J, et al. Targeting of free fatty acid receptor 1 in EOC:A novel strategy to restrict the adipocyte-EOC dependence[J]. Gynecol Oncol, 2016, 141(1):72-79. doi:10.1016/j.ygyno.2016.02.026.
|
[13] |
DOCHEZ V, CAILLON H, VAUCEL E, et al. Biomarkers and algorithms for diagnosis of ovarian cancer:CA125,HE4,RMI and ROMA,a review[J]. J Ovarian Res, 2019, 12(1):28. doi:10.1186/s13048-019-0503-7.
|
[14] |
SENATOROV I S, MONIRI N H. The role of free-fatty acid receptor-4 (FFA4) in human cancers and cancer cell lines[J]. Biochem Pharmacol, 2018, 150:170-180. doi:10.1016/j.bcp.2018.02.011.
|
[15] |
SUN X, CHU H, LEI K, et al. GPR120 promotes metastasis but inhibits tumor growth in pancreatic ductal adenocarcinoma[J]. Pancreatology, 2022, 22(6):749-759. doi:10.1016/j.pan.2022.06.006.
|
[16] |
KLEEMANN J, HRGOVIC I, KLEIMANN P, et al. G protein-coupled receptor 40 expression in human melanoma - correlation with tumour thickness,AJCC stage and survival[J]. J Eur Acad Dermatol Venereol, 2020, 34(2):285-292. doi:10.1111/jdv.15924.
|
[17] |
CUI Z, LI D, LIU J, et al. G-protein-coupled receptor 120 regulates the development and progression of human esophageal cancer[J]. Oncol Rep, 2018, 40(2):1147-1155. doi:10.3892/or.2018.6470.
|
[18] |
NAKASHIMA C, SHINGO K, FUJIWARA-TANI R, et al. Expression of long-chain fatty acid receptor GPR40 is associated with cancer progression in colorectal cancer: A retrospective study[J]. Oncol Lett, 2018, 15(6):8641-8646. doi:10.3892/ol.2018.8383.
|
[19] |
FUKUSHIMA K, TAKAHASHI K, FUKUSHIMA N, et al. Different effects of GPR120 and GPR40 on cellular functions stimulated by 12-O-tetradecanoylphorbol-13-acetate in melanoma cells[J]. Biochem Biophys Res Commun, 2016, 475(1):25-30. doi:10.1016/j.bbrc.2016.05.023.
|